Skip to content

Clinical trials

Phase 3 Carcinoma, Ovarian Epithelial trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 3 Country / region: United Kingdom Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20062
20091
20112
20161
20172
20181
20191
20212
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status4
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical Research Council6
pharmaand GmbH3
AstraZeneca2
European Organisation for Research and Treatment of Cancer - EORTC2
AbbVie1
Amgen1
Daiichi Sankyo1
EBMT Solid Tumors Working Party1
ImmunoGen, Inc.1
Jonsson Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial25
Ovarian Neoplasms22
Fallopian Tube Neoplasms15
Neoplasms2
Peritoneal Neoplasms2
Prostatic Neoplasms2
Recurrence2
Brenner Tumor1
Colorectal Neoplasms1
Endometrial Neoplasms1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.